Rare variants in complex traits: Novel identification strategies and the role of de novo mutations

Human Heredity

Volumn 74, Issue 3-4, 2012, Pages 215-225

  Jouan, Loubna ^a,b   Gauthier, Julie ^a,b   Dion, Patrick A ^a,c   Rouleau, Guy A ^a,b,d  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Autism; De novo; Rare variants; Schizophrenia

Indexed keywords

GENOMIC DNA;

ARTICLE; AUTISM; DE NOVO MUTATION; DISEASE ASSOCIATION; EXOME; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; GENETIC VARIABILITY; HUMAN; HYPOTHESIS; MENTAL DISEASE; SCHIZOPHRENIA; SEQUENCE ANALYSIS;

EID: 84876464821     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000346478     Document Type: Article

References (123)

1. Pulst SM: Genetic linkage analysis. Arch Neurol 1999; 56: 667-672.
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
3. Lifton RP: Genetic dissection of human blood pressure variation: common pathways from rare phenotypes. Harvey Lect 2004; 100: 71-101.
4. Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M: Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 2001; 69: 936-950.
5. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000; 405: 847-856.
6. International HapMap Consortium: The International HapMap Project. Nature 2003; 426: 789-796.
7. International HapMap Consortium: A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
8. International HapMap Consortium, Frazer KA, Ballinger DG, Cox DR, et al: A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449: 851-861.
9. Manolio TA, Brooks LD, Collins FS: A Hap- Map harvest of insights into the genetics of common disease. J Clin Invest 2008; 118: 1590-1605.
10. Rioux JD, Xavier RJ, Taylor KD, et al: Genome- wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39: 596-604.
11. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J: Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
12. Kiezun A, Garimella K, Do R, Stitziel NO, Neale BM, McLaren PJ, Gupta N, Sklar P, Sullivan PF, Moran JL, Hultman CM, Lichtenstein P, Magnusson P, Lehner T, Shugart YY, Price AL, de Bakker PI, Purcell SM, Sunyaev SR: Exome sequencing and the genetic basis of complex traits. Nat Genet 2012; 44: 623-630.
13. Asimit J, Zeggini E: Rare variant association analysis methods for complex traits. Annu Rev Genet 2010; 44: 293-308.
14. Schork NJ, Murray SS, Frazer KA, Topol EJ: Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009; 19: 212-219.
15. Scott LJ, Mohlke KL, Bonnycastle LL, et al: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345.
16. Manolio TA, Collins FS, Cox NJ, et al: Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.
17. Maher B: Personal genomes: the case of the missing heritability. Nature 2008; 456: 18-21.
18. Frazer KA, Murray SS, Schork NJ, Topol EJ: Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009; 10: 241-251.
19. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH: Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010; 11: 446-450.
20. de los Campos G, Gianola D, Allison DB: Predicting genetic predisposition in humans: the promise of whole-genome markers. Nat Rev Genet 2010; 11: 880-886.
21. Meuwissen TH, Hayes BJ, Goddard ME: Prediction of total genetic value using genomewide dense marker maps. Genetics 2001; 157: 1819-1829.
22. Piton A, Gauthier J, Hamdan FF, et al: Systematic resequencing of x-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry 2011; 16: 867-880.
23. Kaufman L, Ayub M, Vincent JB: The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord 2010; 2: 182-209.
24. Laumonnier F, Cuthbert PC, Grant SG: The role of neuronal complexes in human xlinked brain diseases. Am J Hum Genet 2007; 80: 205-220.
25. Pocklington AJ, Cumiskey M, Armstrong JD, Grant SG: The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Mol Syst Biol 2006; 2: 2006.0023.
26. Gauthier J, Siddiqui TJ, Huashan P, et al: Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 2011; 130: 563-573.
27. Glessner JT, Wang K, Cai G, et al: Autism genome- wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459: 569-573.
28. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T; Paris Autism Research International Sibpair Study: Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27-29.
29. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP, Raynaud M, Ronce N, Lemonnier E, Calvas P, Laudier B, Chelly J, Fryns JP, Ropers HH, Hamel BC, Andres C, Barthelemy C, Moraine C, Briault S: X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004; 74: 552-557.
30. Marshall CR, Noor A, Vincent JB, et al: Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82: 477-488.
31. Sudhof TC: Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455: 903-911.
32. Zhang C, Milunsky JM, Newton S, Ko J, Zhao G, Maher TA, Tager-Flusberg H, Bolliger MF, Carter AS, Boucard AA, Powell CM, Sudhof TC: A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J Neurosci 2009; 29: 10843-10854.
33. Pinto D, Pagnamenta AT, Klei L, et al: Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466: 368-372.
34. Francks C, Maegawa S, Lauren J, et al: LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry 2007; 12: 1129-1139, 1057.
35. Gauthier J, Champagne N, Lafreniere RG, et al: De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci USA 2010; 107: 7863-7868.
36. Durand CM, Betancur C, Boeckers TM, et al: Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007; 39: 25-27.
37. Condra JA, Neibergs H, Wei W, Brennan MD: Evidence for two schizophrenia susceptibility genes on chromosome 22q13. Psychiatr Genet 2007; 17: 292-298.
38. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW, Wellman N, Loftus J, Nanthakumar B, Razi K, Stewart J, Comazzi M, Vita A, Heffner T, Sherrington R: A genome- wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry 2002; 159: 803-812.
39. Jorgensen TH, Borglum AD, Mors O, Wang AG, Pinaud M, Flint TJ, Dahl HA, Vang M, Kruse TA, Ewald H: Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands. Am J Med Genet 2002; 114: 245-252.
40. Mowry BJ, Holmans PA, Pulver AE, et al: Multicenter linkage study of schizophrenia loci on chromosome 22q. Mol Psychiatry 2004; 9: 784-795.
41. Vallada H, Curtis D, Sham PC, Murray RM, McGuffin P, Nanko S, Gill M, Owen M, Collier DA: Chromosome 22 markers demonstrate transmission disequilibrium with schizophrenia. Psychiatr Genet 1995; 5: 127-130.
42. Metzker ML: Sequencing technologies - the next generation. Nat Rev Genet 2010; 11: 31-46.
43. Gilissen C, Hoischen A, Brunner HG, Veltman JA: Unlocking Mendelian disease using exome sequencing. Genome Biol 2011; 12: 228.
44. Mardis ER: The impact of next-generation sequencing technology on genetics. Trends Genet 2008; 24: 133-141.
45. Mardis ER: A decade's perspective on DNA sequencing technology. Nature 2011; 470: 198-203.
46. Toydemir RM, Rutherford A, Whitby FG, Jorde LB, Carey JC, Bamshad MJ: Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon- Hall syndrome. Nat Genet 2006; 38: 561-565.
47. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Eichler EE, Bamshad M, Nickerson DA, Shendure J: Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461: 272-276.
48. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, Shendure J, Bamshad MJ: Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet 2010; 42: 30-35.
49. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloglu A, Ozen S, Sanjad S, Nelson-Williams C, Farhi A, Mane S, Lifton RP: Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci USA 2009; 106: 19096-19101.
50. Sobreira NL, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, Stevens EL, Ge D, Shianna KV, Smith JP, Maia JM, Gumbs CE, Pevsner J, Thomas G, Valle D, Hoover-Fong JE, Goldstein DB: Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. PLoS Genet 2010; 6:e1000991.
51. Cirulli ET, Goldstein DB: Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010; 11: 415-425.
52. Pritchard JK, Cox NJ: The allelic architecture of human disease genes: common diseasecommon variant...or not? Hum Mol Genet 2002; 11: 2417-2423.
53. Myers RA, Casals F, Gauthier J, Hamdan FF, Keebler J, Boyko AR, Bustamante CD, Piton AM, Spiegelman D, Henrion E, Zilversmit M, Hussin J, Quinlan J, Yang Y, Lafreniere RG, Griffing AR, Stone EA, Rouleau GA, Awadalla P: A population genetic approach to mapping neurological disorder genes using deep resequencing. PLoS Genet 2011; 7:e1001318.
54. Crow JF: The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet 2000; 1: 40-47.
55. - 1000 Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA: A map of human genome variation from population- scale sequencing. Nature 2010; 467: 1061-1073.
56. Fu YX: Statistical properties of segregating sites. Theor Popul Biol 1995; 48: 172-197.
57. Gibson G: Rare and common variants: twenty arguments. Nat Rev Genet 2012; 13: 135-145.
58. Nelson MR, Wegmann D, Ehm MG, et al: An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 2012; 337: 100-104.
59. Tennessen JA, Bigham AW, O'Connor TD, et al: Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012; 337: 64-69.
60. Coventry A, Bull-Otterson LM, Liu X, et al: Deep resequencing reveals excess rare recent variants consistent with explosive population growth. Nat Commun 2010; 1: 131.
61. Keinan A, Clark AG: Recent explosive human population growth has resulted in an excess of rare genetic variants. Science 2012; 336: 740-743.
62. Eyre-Walker A, Keightley PD: The distribution of fitness effects of new mutations. Nat Rev Genet 2007; 8: 610-618.
63. Cook EH Jr, Scherer SW: Copy-number variations associated with neuropsychiatric conditions. Nature 2008; 455: 919-923.
64. Sanders SJ, Ercan-Sencicek AG, Hus V, et al: Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011; 70: 863-885.
65. Sebat J, Lakshmi B, Malhotra D, et al: Strong association of de novo copy number mutations with autism. Science 2007; 316: 445-449.
66. Veltman JA, Brunner HG: De novo mutations in human genetic disease. Nat Rev Genet 2012; 13: 565-575.
67. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, van Bon BW, Hoischen A, de Vries BB, Brunner HG, Veltman JA: A de novo paradigm for mental retardation. Nat Genet 2010; 42: 1109-1112.
68. Vissers LE, de Vries BB, Veltman JA: Genomic microarrays in mental retardation: from copy number variation to gene, from research to diagnosis. J Med Genet 2010; 47: 289-297.
69. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M: Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008; 40: 880-885.
70. Levy D, Ronemus M, Yamrom B, Lee YH, Leotta A, Kendall J, Marks S, Lakshmi B, Pai D, Ye K, Buja A, Krieger A, Yoon S, Troge J, Rodgers L, Iossifov I, Wigler M: Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011; 70: 886-897.
71. Koolen DA, Pfundt R, de Leeuw N, Hehir- Kwa JY, Nillesen WM, Neefs I, Scheltinga I, Sistermans E, Smeets D, Brunner HG, van Kessel AG, Veltman JA, de Vries BB: Genomic microarrays in mental retardation: a practical workflow for diagnostic applications. Hum Mutat 2009; 30: 283-292.
72. Lindhurst MJ, Sapp JC, Teer JK, et al: A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365: 611-619.
73. Carlson CA, Kas A, Kirkwood R, Hays LE, Preston BD, Salipante SJ, Horwitz MS: Decoding cell lineage from acquired mutations using arbitrary deep sequencing. Nat Methods 2012; 9: 78-80.
74. Piton A, Michaud JL, Peng H, et al: Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet 2008; 17: 3965-3974.
75. Stefansson H, Rujescu D, Cichon S, et al: Large recurrent microdeletions associated with schizophrenia. Nature 2008; 455: 232-236.
76. Awadalla P, Gauthier J, Myers RA, et al: Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet 2010; 87: 316-324.
77. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M: Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25: 63-77.
78. Cardno AG, Gottesman II: Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 2000; 97: 12-17.
79. Malaspina D, Brown A, Goetz D, Alia-Klein N, Harkavy-Friedman J, Harlap S, Fennig S: Schizophrenia risk and paternal age: a potential role for de novo mutations in schizophrenia vulnerability genes. CNS Spectr 2002; 7: 26-29.
80. Kong A, Frigge ML, Masson G, et al: Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012; 488: 471-475.
81. Croen LA, Najjar DV, Fireman B, Grether JK: Maternal and paternal age and risk of autism spectrum disorders. Arch Pediatr Adolesc Med 2007; 161: 334-340.
82. Goriely A, Wilkie AO: Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet 2012; 90: 175-200.
83. Arnheim N, Calabrese P: Understanding what determines the frequency and pattern of human germline mutations. Nat Rev Genet 2009; 10: 478-488.
84. Ku CS, Polychronakos C, Tan EK, Naidoo N, Pawitan Y, Roukos DH, Mort M, Cooper DN: A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry 2012; 18: 141-153.
85. Cooper DN, Bacolla A, Ferec C, Vasquez KM, Kehrer-Sawatzki H, Chen JM: On the sequence- directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease. Hum Mutat 2011; 32: 1075-1099.
86. Conrad DF, Keebler JE, DePristo MA, Lindsay SJ, Zhang Y, Casals F, Idaghdour Y, Hartl CL, Torroja C, Garimella KV, Zilversmit M, Cartwright R, Rouleau GA, Daly M, Stone EA, Hurles ME, Awadalla P, Genomes P: Variation in genome-wide mutation rates within and between human families. Nat Genet 2011; 43: 712-714.
87. Lynch M: Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci USA 2010; 107: 961-968.
88. Itsara A, Wu H, Smith JD, Nickerson DA, Romieu I, London SJ, Eichler EE: De novo rates and selection of large copy number variation. Genome Res 2010; 20: 1469-1481.
89. Eyre-Walker A, Keightley PD: High genomic deleterious mutation rates in hominids. Nature 1999; 397: 344-347.
90. Hamdan FF, Gauthier J, Spiegelman D, et al: Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med 2009; 360: 599-605.
91. Vazquez LE, Chen HJ, Sokolova I, Knuesel I, Kennedy MB: SynGAP regulates spine formation. J Neurosci 2004; 24: 8862-8872.
92. Komiyama NH, Watabe AM, Carlisle HJ, Porter K, Charlesworth P, Monti J, Strathdee DJ, O'Carroll CM, Martin SJ, Morris RG, O'Dell TJ, Grant SG: SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density and NMDA receptor. J Neurosci 2002; 22: 9721-9732.
93. Hamdan FF, Gauthier J, Araki Y, et al: Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 2011; 88: 306-316.
94. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, Mackenzie AP, Ng SB, Baker C, Rieder MJ, Nickerson DA, Bernier R, Fisher SE, Shendure J, Eichler EE: Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011; 43: 585-589.
95. Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, Rowen L, Pant KP, Goodman N, Bamshad M, Shendure J, Drmanac R, Jorde LB, Hood L, Galas DJ: Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010; 328: 636-639.
96. Hoischen A, van Bon BW, Gilissen C, et al: De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 2010; 42: 483-485.
97. Ng SB, Bigham AW, Buckingham KJ, et al: Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010; 42: 790-793.
98. Hoischen A, van Bon BW, Rodriguez-Santiago B, et al: De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet 2011; 43: 729-731.
99. Sanders SJ, Murtha MT, Gupta AR, et al: De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485: 237-241.
100. Iossifov I, Ronemus M, Levy D, et al: De novo gene disruptions in children on the autistic spectrum. Neuron 2012; 74: 285-299.
101. Neale BM, Kou Y, Liu L, et al: Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012; 485: 242-245.
102. O'Roak BJ, Vives L, Girirajan S, et al: Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246-250.
103. Kim Y, Zerwas S, Trace SE, Sullivan PF: Schi zophrenia genetics: where next? Schizophr Bull 2011; 37: 456-463.
104. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, Wellcome Trust Case Control Consortium, Owen MJ, O'Don ovan MC: Gene-wide analyses of genome- wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 2009; 14: 252-260.
105. O'Donovan MC, Kirov G, Owen MJ: Phenotypic variations on the theme of CNVs. Nat Genet 2008; 40: 1392-1393.
106. Stefansson H, Ophoff RA, Steinberg S, et al: Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-747.
107. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
108. Walsh T, McClellan JM, McCarthy SE, et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539-543.
109. Itsara A, Cooper GM, Baker C, Girirajan S, Li J, Absher D, Krauss RM, Myers RM, Ridker PM, Chasman DI, Mefford H, Ying P, Nickerson DA, Eichler EE: Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 2009; 84: 148-161.
110. Sullivan PF, Daly MJ, O'Donovan M: Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012; 13: 537-551.
111. Kirov G, Pocklington AJ, Holmans P, et al: De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142-153.
112. Raychaudhuri S, Korn JM, McCarroll SA, International Schizophrenia Consortium, Altshuler D, Sklar P, Purcell S, Daly MJ: Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet 2010; 6:e1001097.
113. Rujescu D, Ingason A, Cichon S, et al: Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 2009; 18: 988-996.
114. Vacic V, McCarthy S, Malhotra D, et al: Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 2011; 471: 499-503.
115. Lupski JR: Genomic rearrangements and sporadic disease. Nat Genet 2007; 39:S43- S47.
116. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, et al: Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 1995; 92: 7612-7616.
117. Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R, Barnes MR, Larminie C, Jones N, Lennon M, Davies C, Hagan JJ, Scorer CA, Angelinetta C, Akbar MT, Hirsch S, Mortimer AM, Barnes TR, de Belleroche J: Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 2009; 14: 1083-1094.
118. Mei L, Xiong WC: Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008; 9: 437-452.
119. Stephan KE, Friston KJ, Frith CD: Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull 2009; 35: 509-527.
120. Tarabeux J, Champagne N, Brustein E, et al: De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry 2010; 68: 649-656.
121. Betancur C, Sakurai T, Buxbaum JD: The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci 2009; 32: 402-412.
122. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L, Dionne-Laporte A, Spiegelman D, Henrion E, Diallo O, Thibodeau P, Bachand I, Bao JY, Tong AH, Lin CH, Millet B, Jaafari N, Joober R, Dion PA, Lok S, Krebs MO, Rouleau GA: Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 2011;43: 860-863.
123. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M: Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 2011; 43: 864-868.